| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |